Oral fluoroquinolone use and the risk of aortic and mitral valve regurgitation: a nationwide cohort study
In a nationwide cohort study, there was no statistical support for an increase in the risk of mitral or aortic valve regurgitation associated with oral fluoroquinolone use.
Authors
- Malin Inghammar (ORCID: https://orcid.org/0000-0003-2995-1312)
- Olof Nibell
- Jonas Björk
Institutions
- Lund University (SE)
- Skåne University Hospital (SE)
Publication Details
- Journal
- BMJ Open
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1136/bmjopen-2024-096783
- Primary Topic
- Antibiotics Pharmacokinetics and Efficacy
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Skånes universitetssjukhus